Polar Capital Holdings’s Ascendis Pharma A/S ASND Stock Holding History

Polar Capital Holdings’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$149M	Buy	651,712 +281,239	+76%	+$63M	0.53%	48
2025 Q4	$79M	Sell	370,473 -487,438	-57%	-$101M	0.31%	76
2025 Q3	$171M	Buy	857,911 +20,134	+2%	+$3.76M	0.82%	33
2025 Q2	$145M	Buy	837,777 +312,777	+60%	+$50.9M	0.76%	40
2025 Q1	$81.8M	Buy	525,000 +225,000	+75%	+$32.1M	0.5%	55
2024 Q4	$41.3M	Buy	300,000 +75,000	+33%	+$9.86M	0.23%	110
2024 Q3	$33.6M	Buy	+225,000	New	+$30.4M	0.16%	112
2021 Q2	–	Sell	-2,524	Closed	-$325K	–	355
2021 Q1	$325K	Sell	2,524 -50,000	-95%	-$7.6M	﹤0.01%	314
2020 Q4	$8.76M	Buy	+52,524	New	+$8.69M	0.05%	219

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Polar Capital Holdings's ASND Position: Q1 2026 in Review

Polar Capital Holdings increased its Ascendis Pharma A/S (ASND) stake by 76% in Q1 2026, buying an estimated $63M and bringing the position to 651,712 shares worth $149M. The position accounts for 0.53% of the portfolio, ranked #48.

Polar Capital Holdings first reported a position in ASND in Q4 2020 and has held it in 9 quarters since. The position peaked at $171M in Q3 2025. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

Polar Capital Holdings held 651,712 shares of Ascendis Pharma A/S worth $149M as of Q1 2026.
Polar Capital Holdings bought 281,239 Ascendis Pharma A/S shares in Q1 2026, an estimated $63M.
Ascendis Pharma A/S made up 0.53% of Polar Capital Holdings's portfolio in Q1 2026, its #48 holding.
Polar Capital Holdings first reported a position in Ascendis Pharma A/S in Q4 2020 and has held it in 9 quarters since.
Polar Capital Holdings's Ascendis Pharma A/S position peaked at $171M in Q3 2025.
273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Polar Capital Holdings's 13F filing for Q1 2026, filed 15 May 2026.